After a successful inaugural year, the SGO and GOG-F (GOG Foundation, Inc.) are proud to join forces and, with the support of the Foundation for Women’s Cancer (FWC), launch BRIDGES 2.0, an expanded two-year program!
The SGO/GOG-F BRIDGES 2.0 Research Initiative is a longitudinal clinical trials program for early career investigators with the aim of developing the next generation of trialists who will lead investigator-initiated and cooperative group gynecologic cancer clinical studies. It is designed to bridge the gap between translational scientists and clinical trialists in gynecologic oncology by providing formal training for early-career investigators in clinical trial design, connecting participants with expert mentors, and supporting the development of novel clinical trials.
The 2024-2025 program is generously supported by grants from the Ovarian Cancer Research Alliance, GSK, AstraZeneca, Merck, and Seagen.